Year | Document | Report |
---|
The Consolidated unclaimed/ unpaid dividend details as required by the Investor Education and Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying with companies) Rules, 2012, are provided herein below for all the unclaimed/unpaid dividend accounts outstanding for the respective financial years.
Pursuant to Regulation 39(4) of Listing Regulations read with Schedule VI of the said Regulations, the Company has dematerialized shares which have been returned undelivered by postal authorities and shares lying unclaimed. The dematerialized shares are held in an ‘unclaimed suspense account’ opened with Karvy Stock Broking Limited.
Any corporate benefits accruing on such shares, viz. bonus shares, split etc., shall also be credited to unclaimed suspense account, for a period of seven years and thereafter shall be transferred by the Company to Investor Education and Protection Fund (IEPF), in accordance with provisions of Section 124(5) and (6) of the Companies Act, 2013 and rules made thereunder.
In accordance with the provisions of the Listing Regulations, the Company reports the following details in respect of equity shares lying in the suspense account.Particulars | Number of shareholders | Number of equity shares |
---|---|---|
Aggregate number of shareholders and the outstanding shares in the suspense account lying at the beginning of the year | 1,139 | 70,371 |
Shareholders who approached the Company for transfer of shares from suspense account during the year | 20 | 2,104 |
Shareholders to whom shares were transferred from the suspense account during the year | 20 | 2,104 |
Aggregate number of shareholders and shares which were transferred to IEPF as per the MCA Circular | 23 | 289 |
Aggregate number of shareholders and the outstanding shares in the suspense account lying as on March 31, 2019 | 1,096 | 67,978 |
The voting rights on the shares outstanding in the suspense account as on March 31, 2020 shall remain frozen till the rightful owner claims the shares.
In accordance with the provisions of Sections 124 and 125 of Companies Act, 2013 and Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (IEPF Rules) dividends not encashed/ claimed within seven years from the date of declaration are to be transferred to the Investor Education and Protection Fund (IEPF) Authority.
The IEPF Rules mandate companies to transfer shares of Members whose dividends remain unpaid/ unclaimed for a continuous period of seven years to the demat account of IEPF Authority. The Members whose dividend/ shares are transferred to the IEPF Authority can claim their shares/ dividend from the Authority.
In accordance with the said IEPF Rules and its amendments, the Company had sent notices to all the Shareholders whose shares were due to be transferred to the IEPF Authority and simultaneously published newspaper advertisements.
In terms of the provisions of IEPF Rules and Investor Education and Protection Fund (Awareness and Protection of Investors) Rules, 2001, Rs. 11,20,750 of unpaid/ unclaimed dividends and 8,454 shares were transferred during the financial year 2019-20 to the IEPF including the dividend amounts declared and paid by erstwhile Shasun Pharmaceuticals Limited.
The Company has appointed Ms. Manjula Ramamurthy, Company Secretary as the Nodal Officer of the Company under the provisions of IEPF, the details of which are available on the website of the Company.
Company has uploaded the details of unpaid and unclaimed amounts lying with the Company as on March 31, 2020 on the Company’s website.
Due date for transfer of unpaid/ unclaimed dividend to IEPF is as follows:Financial Year Ending | Type of Dividend | Dividend Rate |
Date of declaration | Due date for transfer to IEPF |
---|---|---|---|---|
31 December 2012 | Final | 20% | 10 June 2013 | 16 July 2020 |
31 March 2014 | Special | 5000% | 10 December 2013 | 15 January 2021 |
Final | 50% | 09 September 2014 | 15 October 2021 | |
31 March 2015 | Special | 1050% | 07 October 2014 | 12 November 2021 |
Final | 30% | 30 July 2015 | 04 September 2022 | |
31 March 2016 | Final | 40% | 29 July 2016 | 03 September 2023 |
31 March 2017 | Final | 45% | 15 September 2017 | 21 October 2024 |
31 March 2018 | Final | 20% | 24 September 2018 | 30 October 2025 |
31 March 2019 | Final | 30% | 30 July 2019 | 04 September 2026 |
31 March 2020 | Interim | 120% | 29 July 2019 | 03 September 2026 |
Fractional Shares Account * | ||||
27 January 2016 | NA | NA | NA | 03 March 2023 |
Unclaimed Shares Suspense Account** | ||||
17 August 2016 | NA | NA | NA | 22 September 2023 |
* Arising on account of sale of fractional shares pursuant to merger of Shasun with Strides.
** Pursuant to unclaimed shares considered into Suspense Account as per Listing Regulations.
Due dates for transfer of unpaid/ unclaimed dividends to IEPF relating to erstwhile Shasun Pharmaceuticals Limited which got merged with the Company effective November 19, 2015 is as follows:
Financial Year Ending | Type of Dividend | Dividend Rate |
Date of declaration | Due date for transfer to IEPF |
---|---|---|---|---|
31 March 2013 | Final | 75% | 02 Aug 2013 | 07 September 2020 |
31 March 2014 | Final | 50% | 06 Aug 2014 | 11 September 2021 |
31 March 2016 | Interim | 50% | 30 July 2015 | 04 September 2022 |
The Members of the Company, who have not yet encashed their dividend, may write to the Company/ Registrar and Share Transfer Agents immediately.
The Company's shares are traded in dematerialised form. The Company has established connectivity with both the Depositories viz., National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) through the Registrar, Karvy Fintech Private Limited.
As at March 31, 2019, 99.83% of the paid-up share capital of the Company representing 89,396,070 shares has been dematerialised and balance 0.17% representing 153,406 shares of the Company is in physical form.
Updation of PAN and Bank Details of Shareholders
Pursuant to SEBI circular bearing reference SEBI/HO/MIRSD/DOP1/CIR/P/2018/73 dated April 20, 2018, the Company through its Registrar and Transfer Agents has initiated collection of copies of PAN and bank account details of the shareholders holding shares in physical form.
In this connection, Company has sent reminders to shareholders holding shares in physical form, requesting them to register/ update their PAN and bank account details. For ease of shareholders and effective updation, Company has provided postage paid/ pre-paid Business Reply Envelopes (BRE).
SEBI restriction on transfer of physical shares
SEBI vide its Notification no. SEBI/ LAD-NRO/GN/2018/24 has notified that with effect from December 5, 2018, except in case of transmission or transposition of securities, requests for effecting the transfer of securities shall not be processed unless the securities are held in the dematerialized form with a depository. Listing Regulations are appropriately amended to this effect.
In other words, there will not be any transfer of physical shares after 5 Dec 2018.
The said measure of SEBI is aimed at curbing fraud and manipulation risk in physical transfer of securities by unscrupulous entities. Transfer of securities only in demat form will improve ease, convenience and safety of transactions for investors.
Shareholders who continue to hold shares in physical form are advised to dematerialize their shares at the earliest. For any clarification, assistance or information relating to dematerialization of shares – members may contact the Company’s RTA.
Ms. Manjula Ramamurthy
Company Secretary
Strides Pharma Science Limited
Bangalore – 560 076
Ph: +91 80 6784 0734
Mob: +91 9880667807
Email:
Manjula.r@strides.com
investors@strides.com